Afatinib Versus Methotrexate as Second-Line Treatment in Asian Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Progressing on or After Platinum-Based Therapy (LUX-Head & Neck 3): An Open-Label, Randomised Phase III Trial
KEY PUBLICATIONS IN RECURRENT/METASTATIC HEAD AND NECK CANCERS
Chairpersons :
K Pavithran, Medical Oncologist, Kochi Govind Babu, Medical Oncologist, Bangalore P K Julka, Radiation Onclogist, Delhi
Speaker :
Sandeep Goyle